Janux Therapeutics (JANX)
(Delayed Data from NSDQ)
$49.99 USD
+1.07 (2.19%)
Updated May 13, 2024 04:00 PM ET
After-Market: $49.95 -0.04 (-0.08%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.29 | 10.34% |
Earnings Summary
For their last quarter, Janux Therapeutics (JANX) reported earnings of -$0.30 per share, beating the Zacks Consensus Estimate of $-0.35 per share. This reflects a positive earnings surprise of 14.29%. Look out for JANX's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.29 per share, reflecting a year-over-year increase of 30.95%.
Earnings History
Price & Consensus
Zacks News for JANX
Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength
JANX: What are Zacks experts saying now?
Zacks Private Portfolio Services